Otherwise I would have given a higher score
Unlike sleep-promoting peptides like DSIP , AOD 9604 is neutral regarding sleep
Safety Profile IGF-1 LR3 has been extensively studied in research settings and shows a predictable side effect profile when used responsibly
SeekPeptides has compiled this evidence-based resource to help researchers navigate the complex landscape of metabolic optimization compounds
Active cancer or history of malignancy Pregnancy or breastfeeding Known peptide allergies Athletes subject to anti-doping testing (WADA prohibited) Raynauds disease or phenomenon Cold urticaria (hives from cold) Uncontrolled hypertension Peripheral vascular disease Open wounds (for local application) Pregnancy Cardiovascular conditions Diabetes (especially with neuropathy) Current infections Immunosuppression Blood clotting disorders Quality control issues represent perhaps the greatest practical risk with BPC-157
PubMed Goldstein, A.L., Hannappel, E., Sosne, G., & Kleinman, H.K
